[Skip to Navigation]
JAMA Network Clinical Guideline Synopsis
August 10, 2020

Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder

Author Affiliations
  • 1Department of Pediatrics, Stanford University School of Medicine, Stanford, California
JAMA Pediatr. 2021;175(2):191-192. doi:10.1001/jamapediatrics.2020.2218

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental condition that affects nearly 1 in 10 children and significantly affects academic achievement, well-being, and social interactions.1 Although ADHD is usually diagnosed in childhood and continues through adolescence and adulthood,2 many children remain untreated or undertreated.3 Comorbid conditions, such as learning and language disorders, anxiety, depression, oppositional defiant disorder, and conduct disorder, are commonly associated with ADHD and often missed.

Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words